Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Rhythm Pharmaceuticals Inc shares valued at $314,013 were purchased by JOSEPH SHULMAN on Oct 28 ’25. At $111.55 per share, JOSEPH SHULMAN acquired 2,815 shares.
Also, Shulman Joseph sold 14,437 shares, netting a total of over 1,617,337 in proceeds. Following the sale of shares at $112.03 each, the insider now holds 8,509 shares.
Before that, JOSEPH SHULMAN had added 14,437 shares to its account. In a trade valued at $1,578,686, the Officer bought Rhythm Pharmaceuticals Inc shares for $109.35 each.
As published in their initiating research note from Goldman on July 10, 2025, Rhythm Pharmaceuticals Inc [RYTM] has been a Buy and the price target has been revised to $97. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in early July. As of April 07, 2025, BofA Securities has increased its “Neutral” rating to a “Buy” for RYTM.
Analyzing RYTM Stock Performance
On last trading session, Rhythm Pharmaceuticals Inc [NASDAQ: RYTM] rose 0.38% to $113.89. The stock’s lowest price that day was $110.92, but it reached a high of $114.59 in the same session. During the last five days, there has been a surge of approximately 4.32%. Over the course of the year, Rhythm Pharmaceuticals Inc shares have jumped approximately 134.58%. Shares of the company reached a 52-week high of $115.12 on 10/28/25 and a 52-week low of $45.90 on 04/07/25.
Support And Resistance Levels for Rhythm Pharmaceuticals Inc (RYTM)
According to the 24-hour chart, there is a support level at 111.68, which, if violated, would cause prices to drop to 109.46. In the upper region, resistance lies at 115.35. The next price resistance is at 116.80. RSI (Relative Strength Index) is 69.07 on the 14-day chart, showing neutral technical sentiment.
Is Rhythm Pharmaceuticals Inc subject to short interest?
Stocks of Rhythm Pharmaceuticals Inc saw a sharp rise in short interest on 2025-10-15 jumping by 0.35 million shares to 5.57 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 5.22 million shares. A jump of 6.34% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.06 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.06.
Which companies own the most shares of Rhythm Pharmaceuticals Inc (RYTM)?
In terms of Rhythm Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 129 in the next 12 months, up nearly 13.7% from the previous closing price of $113.46. Analysts anticipate Rhythm Pharmaceuticals Inc stock to reach 142 by 2025, with the lowest price target being 110. In spite of this, 5 analysts ranked Rhythm Pharmaceuticals Inc stock as Buy at the end of 2025. On January 02, 2025, Jefferies assigned a price target of “a Buy” to the stock and initiated coverage with a $80.
